Navigation Links
The American Society for Microbiology honors George L. Drusano
Date:6/20/2013

The winner of the esteemed Cubist-ICAAC Award is George L. Drusano, M.D., Institute for Therapeutic Innovation of the University of Florida, for his application of pharmacokinetic and pharmacodynamic modeling to antiviral and antimicrobial drug development. According to his nominator, Michael Dudley, Rempex Pharmaceuticals, "Drusano and his colleagues have published groundbreaking work using pharmacokinetics/pharmacodynamics to simulate and then validate dosing regimens to maximize the safety and efficacy of antibiotics. The breadth and importance of his work is remarkable."

After graduating magna cum laude, ΦΒΚ from the Honors Program at Boston College, Drusano received his M.D. from the University of Maryland School of Medicine where he graduated cum laude, ΑΩΑ. He completed his medical internship and residency at the University of Maryland Hospital, where he was Chief Resident and also a Fellow in Medicine in Infectious Diseases.

Drusano, a Fellow of the American Academy of Microbiology and the Infectious Diseases Society of America (IDSA), is an active reviewer and has served as editor of the section of pharmacology and experimental therapeutics for Antimicrobial Agents and Chemotherapy for 10 years. Currently he is an Editor for mBio. He has authored over 290 articles.

Also an active volunteer, Drusano was a member of the Interscience Conference on Antimicrobial Agents and Chemotherapeutics (ICAAC) Program Committee and the IDSA Program Committee. He has served on multiple National Institute of Allergy and Infectious Diseases (NIAID) Review Groups and as an ad hoc member of NIAID Council on two occasions to support issues regarding emergence of bacterial resistance. He also serves as a consultant to NIAID and CDC on Biodefense issues. Drusano has been a member of the Subcommittee on Guidelines for Bacteremia and Endocarditis of the Antimicrobial Agents Use Committee, a joint effort of the IDSA and the Food and Drug Administration. In 2010, he was Chair of the Gordon Conference on New Antimicrobial Discovery and Development. He has won a number of awards, including being named Distinguished Investigator of the Year (2003) by the American College of Clinical Pharmacology. Most recently, he was named recipient of the Maxwell Finland Award for Scientific Achievement for 2012 from the National Foundation for Infectious Diseases.

An active researcher, Drusano has focused on mathematical modeling and the pharmacodynamics of anti-infective chemotherapy, especially the pharmacodynamics of fluoroquinolone antimicrobials, anti-tuberculosis agents, multiple anti-viral agents and the therapy of biodefense pathogens. Paul G. Ambrose, Institute for Clinical Pharmacodynamics, says, "Drusano is a distinguished scholar and scientist who pioneered work in anti-infective pharmacology and antimicrobial resistance, and helped redefine infectious disease chemotherapy as we know it today."


'/>"/>

Contact: Garth Hogan
ghogan@asmusa.org
202-942-9389
American Society for Microbiology
Source:Eurekalert

Related biology news :

1. The American Society for Microbiology honors Ken Cadwell
2. American Chemical Society global program tackles safe drinking water in Colombia
3. The American Society for Microbiology honors Marc Torrent
4. The American Society for Microbiology honors Joshua Obar
5. AMP joins the Federation of American Societies for Experimental Biology
6. American Chemical Societys highest honor goes to Stephen J. Lippard, Ph.D.
7. Medicine, energy topics of Kavli lectures at American Chemical Society meeting
8. Save the date: American Chemical Society National Meeting, Sept. 8-12, 2013, in Indianapolis
9. Body mass index of low income African-Americans linked to proximity of fast food restaurants
10. OU microbiologists elected as fellows in the American Academy of Microbiology
11. American Chemical Society resource connects scientists, discoveries, chemistry & biology interface
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , Feb. 11, 2016  Vigilant Solutions announces today that ... are being used by Lee,s Summit ... recent location and arrest of a homicide suspect. ... covers around 65 square miles and is home to ... Department has a single mobile license plate reader system and ...
(Date:2/5/2016)... 2016 http://www.researchandmarkets.com/research/5kvw8m/global_facial ) ... "Global Facial Recognition Market 2016-2020" report ... ) has announced the addition of the ... report to their offering. --> ... announced the addition of the "Global ...
(Date:2/3/2016)... http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) ... "Emotion Detection and Recognition Market by Technology ... Tools (Facial Expression, Voice Recognition and Others), ... Global forecast to 2020" report to ... ) has announced the addition of the ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... WASHINGTON , Feb. 11, 2016   BioInformant ... strategic report, "Stem Cell Research Products, Opportunities, Tools, and ... 2020. ... specialize in the stem cell industry, BioInformant has more ... of the stem cell market, by stem cell type. ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... its new stem cell treatment clinic in Quito, Ecuador. The new facility will ... trauma applications to patients from around the world. , The new GSCG ...
(Date:2/10/2016)... 10, 2016  The Maryland House of Delegates and ... that University of Maryland School of Medicine Dean ... of Maryland Medical System President and CEO Robert ... the highest honor given to the public by the ... Dean Reece and Mr. Chrencik for their contributions ...
(Date:2/10/2016)... York, and New York, New York (PRWEB) , ... ... ... Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) today announced that it has ... develop new vaccines and immunotherapies for infectious diseases and cancer. , ...
Breaking Biology Technology: